Annual Risk of Major Bleeding Among Persons Without Cardiovascular Disease Not Receiving Antiplatelet Therapy

IMPORTANCE: A decision to initiate aspirin therapy for primary prevention of cardiovascular disease (CVD) requires consideration of both treatment benefits and harms. The most significant harm associated with aspirin is major bleeding, yet there is a paucity of data on bleeding risk in suitable comm...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:JAMA
Κύριοι συγγραφείς: Selak, Vanessa, Kerr, Andrew, Poppe, Katrina, Wu, Billy, Harwood, Matire, Grey, Corina, Jackson, Rod, Wells, Sue
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Medical Association 2018
Θέματα:
Original Investigation
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583689/
https://ncbi.nlm.nih.gov/pubmed/29946729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2018.8194
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια